Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5558 USD | +6.48% | +7.34% | +2.30% |
03-22 | Sangamo Therapeutics Prices $24 Million Registered Direct Offering | MT |
03-14 | Sangamo Therapeutics Pushes Neurology Programs Toward Clinical Development, Wedbush Says | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.30% | 108M | |
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Sangamo Therapeutics : Wedbush Trims Price Target for Sangamo Therapeutics to $11 From $12, Maintains Neutral Rating